Case studies
Merck & Co., Inc. posed a challenge: How could the company help dramatically improve the health of people with HIV in the U.S.? We conducted in-depth research and engaged more than 100 thought leaders and service providers to envision an optimal system in which everyone at-risk was tested, everyone infected promptly entered care – and then stayed there.
read more
The United States routinely screens teens for vision and hearing loss, but not for a mental illness. For more than a decade, we worked with the TeenScreen National Center for Mental Health Checkups at Columbia University to expand teen mental health screening to 43 states. Now major insurers, primary care providers and more than 500 schools and community organizations offer a free mental health check-up for teenagers.
read more
The objective of medical research is to develop interventions to improve the health of individuals, communities and populations. But many women, especially those who are pregnant, have been left out when it comes to testing the effectiveness of new medicines. We helped convene a conference in Geneva, Switzerland to raise awareness and explore potential solutions on this issue.
read more
In 2010 the UN Foundation, on behalf of the United Nations Secretary-General, retained Rabin Martin to design and implement a global strategy and effort to meet health development goals for women and children. Secretary-General Ban Ki-moon, along with global leaders from a wide range of sectors, joined in the launch of a concerted worldwide effort to save the lives of more than 16 million women and children.
read more
Black Americans represent the largest population affected by HIV/AIDS in the United States, making up 51% of cases, but they remain the group least enrolled in care. We provided technical, strategic and communications support to BTAN, a unique collaboration that links Black Americans with HIV into care and treatment, strengthens leadership and advocates for policy change and research priorities.
read more
Novo Nordisk came to us with a question: How could the company help improve access to diabetes care for patients around the world? We initiated a comprehensive re-assessment of the company’s access strategy, benchmarked novel approaches and gained feedback from more than 40 stakeholders, helping Novo Nordisk identify the opportunity to build on its legacy as the leading diabetes company in the world by working to close the global gap in access to insulin.
read more
